Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis

Journal of Pediatrics

Volumn 141, Issue 2, 2002, Pages 178-185

  Lepage, Guy ^a   Yesair, David W ^a   Ronco, Nancy ^a   Champagne, Josée ^a   Bureau, Nathalie ^a   Chemtob, Sylvain ^a   Bérubé, Denis ^a   Roy, Claude C ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; FATTY ACID; LIPID; LYSOPHOSPHATIDYLCHOLINE; ORGANIZED LIPID MATRIX; RETINOL BINDING PROTEIN; RETINOL PALMITATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PRESSURE; ADOLESCENT; APPETITE DISORDER; AREA UNDER THE CURVE; ARTICLE; BODY HEIGHT; CALORIC INTAKE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENERGY METABOLISM; FAT CONTENT; FAT INTAKE; FECES ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTESTINE ABSORPTION; LIPID ABSORPTION; LIPID METABOLISM; MALE; METEORISM; NUTRIENT AVAILABILITY; OBSERVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0036694842     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.124305     Document Type: Article

References (36)

1. Ramsey BW, Farrell PM, Pencharz PB. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992;55:108-16.
2. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
3. Feranchak AP, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 1999;135:601-10.
4. Lepage G, Levy E, Ronco N, Smith L, Galéano N, Roy CC. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res 1989;30: 1483-90.
5. Roulet M, Frascarolo P, Rappaz I, Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 1997;156:952-6.
6. van Egmond AWA, Kosorok MR, Koscik R, Laxova A, Farrell PM. Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr 1996;63:746-52.
7. Lepage G, Paradis K, Lacaille F, Sénéchal L, Ronco N, Champagne J, et al. Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis. J Pediatr 1997;130:52-8.
8. Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT. Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. Acta Paediatr 1996;85:1426-32.
9. Yesair DW. Phosphatidyl choline and lysophosphatidyl choline in mixed lipid micelles as novel drug delivery systems. In: Hanin I, Pepeu G, editors. Phospholipids. New York: Plenum Press; 1990. p. 83-106.
10. Pencharz PB, Durie PR. Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr 2000;19:387-94.
11. Levy E, Lepage G, Bendayan M, Ronco N, Thibault L, Galéano N, et al. Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients. J Lipid Res 1989;30: 1197-209.
12. Lepage G, Champagne J, Ronco N, Lamarre A, Osberg I, Sokol RJ, et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1996;64:87-93.
13. Benabdeslam H, Garcia I, Bellon G, Gilly R, Revol A. Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts. Am J Clin Nutr 1998; 67:912-8.
14. Grey V, Lands LC, Pall H, Drury D. Monitoring of 25-OH vitamin D levels in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2000;30:314-9.
15. Rashid M, Durie P, Andrew M, Kalnins D, Shin J, Corey M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 1999;70:378-82.
16. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275:539-44.
17. Winer BJ. Design and analysis of factorial experiments. In: Winer BJ, editor. Statistical principles in experimental design. New York: McGraw-Hill Book Company; 1971. p. 309-430.
18. Rampone AJ, Long LR. The effect of phosphatidylcholine and lysophosphatidylcholine on the absorption and mucosal metabolism of oleic acid and cholesterol in vitro. Biochim Biophys Acta 1977;486:500-10.
19. Homan R, Hamelehle KL. Phospholipase A2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transport by human intestinal cell line Caco-2. J Lipid Res 1998;39:1197-209.
20. Viola G, Mietto L, Secchi FE, Ping L, Bruni A. Absorption and distribution of arachidonate in rats receiving lysophospholipids by oral route. J Lipid Res 1993;34:1843-52.
21. Jelalian E, Stark LJ, Reynolds L, Seifer R. Nutrition intervention for weight gain in cystic fibrosis: a meta analysis. J Pediatr 1998;132:486-92.
22. Gaskin KJ, Waters DL, Baur LA, Soutter VL, Gruca MA. Nutritional status, growth and development in children undergoing intensive treatment for cystic fibrosis. Acta Paediatr Scand Suppl 1990;366:I06-10.
23. Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG, et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 1998; 132:478-85.
24. Christophe A, Robberecht E, Franckx H, De Baets F, Van de Pas M. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann Nutr Metab 1994;38:40-7.
25. Bhura-Bandali FN, Suh M, Man SF, Clandinin MT. The Delta F508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J Nutr 2000;130:2870-5.
26. Rettammel AL, Marcus MS, Farrell PM, Sondel SA, Koscik RE, Mischler EH. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis. J Am Diet Assoc 1995;95:454-9.
27. Manku MS, Morse-Fisher NM, Horrobin DF. Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid and gamma-linolenic acid. Eur J Clin Nutr 1988;42:55-60.
28. Ackman RG, Cunnane SC. Long-chain polyunsaturated fatty acids. In: FB Padley, editor. Advances in applied lipid research. London: JAI Press; 1991. p. 161-215.
29. Mischler EH, Parrell SW, Farrell PM, Raynor WJ, Lemen RJ. Correction of linoleic acid deficiency in cystic fibrosis. Pediatr Res 1986;20:36-41.
30. Parsons HG, O'Loughlin EV, Forbes D, Cooper D, Gall DG. Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res 1988;24:353-6.
31. Hubbard VS. What is the association of essential fatty acid status with cystic fibrosis? Eur J Pediatr 1983;141:68-70.
32. Koo SI, Noh SK. Phosphatidylcholine inhibits and lysophosphatidylcholine enhances the lymphatic absorption of α-tocopherol in adult rats. J Nutr 2001;131:717-22.
33. Strandvik B, Svensson E, Seyberth HW. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 1996;55:419-25.
34. Zemel BS, Kawchak DA, Cnaan A, Zhao HQ, Scanlin TF, Stallings VA. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis. Pediatr Res 1996;40:578-86.
35. Dalzell AM, Shepherd RW, Dean B, Cleghorn GJ, Holt TL, Francis PJ. Nutritional rehabilitation in cystic fibrosis: a 5 year follow-up study. J Pediatr Gastroenterol Nutr 1992;15: 141-5.
36. Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr 1994;124:244-9.